SRPT
Sarepta Therapeutics margins
- Stocks
- Healthcare
- NASDAQ: SRPT
- Margins
At present, Sarepta Therapeutics currently has a gross margin of 59.1%, an operating margin of -7.3%, an EBITDA margin of -3.7%, and a net margin of -6.9%; its operating margin is negative at -7.3%, its EBITDA margin is negative at -3.7%, and its net margin is negative at -6.9%. Gross margin had the largest decline, decreasing by 20.2 percentage points, while the other available margins also declined.
SRPT margin history
Sarepta Therapeutics's margins averaged 77.7% gross, -5.53% operating, -3.25% EBITDA, and -7.27% net during the last 3 years. Sarepta Therapeutics's current metrics show that net margin is above its three-year average and gross, operating, and EBITDA margins are below their three-year averages.
SRPT margin expansion
Sarepta Therapeutics's gross margin contracted by 20.2 percentage points, operating margin by 7.3 percentage points, EBITDA margin by 5 percentage points, and net margin by 4.6 percentage points, led by gross margin with a decline of 20.2 percentage points.
SRPT Gross margin
Over the last 3 years, the average gross margin for Sarepta Therapeutics was 77.7%. The latest gross margin for Sarepta Therapeutics is 59.1%, 18.6 percentage points below its three-year average. Sarepta Therapeutics's gross margin ranged from a low of 59.1% in Jun 2026 to a high of 88.3% in Jun 2024.
SRPT Operating margin
Looking at the last 3 years, Sarepta Therapeutics had an average operating margin of -5.53%. Against its three-year average, Sarepta Therapeutics's operating margin is currently -7.3%, 1.8 percentage points below its three-year average. Looking back over the last 3 years, Sarepta Therapeutics's operating margin reached 11.5% at its highest point in Dec 2024 and -31.8% at its lowest in Dec 2025.
SRPT EBITDA margin
Across the last 3 years, Sarepta Therapeutics had an average EBITDA margin of -3.25%. Against its three-year average, Sarepta Therapeutics's EBITDA margin is currently -3.7%, 0.5 percentage points below its three-year average. Looking back over the last 3 years, Sarepta Therapeutics's EBITDA margin reached 16.5% at its highest point in Dec 2024 and -37.1% at its lowest in Dec 2023.
SRPT Net margin
Over the last 3 years, the average net margin for Sarepta Therapeutics was -7.27%. The latest net margin for Sarepta Therapeutics is -6.9%, 0.4 percentage points above its three-year average. Sarepta Therapeutics's net margin ranged from a low of -43.1% in Dec 2023 to a high of 12.4% in Dec 2024.
SRPT margin group comparison
Sarepta Therapeutics's gross margin of 59.1% is below the Healthcare sector, the industry and its peers average. Compared to its Healthcare sector average of 68.3%, Sarepta Therapeutics's gross margin is 13% lower.
SRPT margin peer comparison
Frequently asked questions
What is Sarepta Therapeutics's gross margin?
As of Jun 30, 2026, SRPT has a gross margin of 59.1%.
What is Sarepta Therapeutics's operating margin?
As of Jun 30, 2026, SRPT has an operating margin of -7.3%.
What is Sarepta Therapeutics's EBITDA margin?
For the period ending Jun 30, 2026, SRPT recorded an EBITDA margin of -3.7%.
What is Sarepta Therapeutics's net margin?
As of Jun 30, 2026, SRPT has a negative net margin of -6.9%.
What are the average margins of SRPT?
The three-year average margins for SRPT were 77.7% gross, -5.5% operating, -3.3% EBITDA, and -7.3% net.
What are the highest historical margins of SRPT?
Within the 5-year period, SRPT recorded its highest margins at 88.3% gross in Jun 2024, 11.5% operating in Dec 2024, 16.5% EBITDA in Dec 2024, and 12.4% net in Dec 2024.
What are the lowest historical margins of SRPT?
Looking back across 5 years, SRPT reached its lowest margins at 59.1% gross in Jun 2026, -65.5% operating in Dec 2021, -107% EBITDA in Mar 2023, and -114.3% net in Mar 2023.